Gastric Cancer Clinical Trials 2024

What are the top hospitals conducting gastric cancer research?

When it comes to cutting-edge clinical trials in the battle against gastric cancer, several top hospitals are leading the way. The M D Anderson Cancer Center in Houston has established itself as a frontrunner with four ongoing gastric cancer trials and an impressive track record of 18 completed studies since their inaugural trial in 2007. Meanwhile, at the Dana-Farber Cancer Institute in Boston, researchers are currently engaged in three active clinical trials for gastric cancer while having conducted a total of 19 previous studies since commencing research on this condition back in 2000.

It is worth noting that Memorial Sloan Kettering Cancer Center (All Protocol Activities) located in New york City demonstrates remarkable progress despite recording only one lifetime trial regarding gastric cancer; they have recently launched three active clinical investigations focusing on finding novel approaches towards combating this disease as early as last year -2020.The City of Hope Medical Center situated in Duarte also plays a significant role within this field, boasting three ongoing gastric cancer trials and contributing to elevating scientific understanding through participation among eleven previously held investigations originating from their initial experiment initiated around ten years ago-2011.Besides these accomplishments intersecting with Texas State,the University of Texas MD Anderson Cancer Center based out of Houston embarks upon similar initiatives showcasing revolutionary means regarding treating stomach cancers wherein they participate across series such as comprehensive groundbreaking research revolving around probing strategies for improvements by indulging into three contemporarily observed experiments pertaining specifically to Gastric Cancers along with expanding insights via seven preceding projects starting from their preliminary discovery about potential new paradigms nearly twelve years past till date.

These esteemed institutions not only offer hope but also provide platforms for innovation and collaboration. Every breakthrough made through these clinical trials brings us closer to improved treatment options and ultimately increases survival rates for individuals battling against gastric cancer globally

Which are the best cities for gastric cancer clinical trials?

When it comes to gastric cancer clinical trials, several cities emerge as leaders in research and development. Anchorage, Alaska boasts 18 active trials delving into treatments like Radiation Therapy and targeted therapies for specific mutations. Houston, Texas follows closely behind with 16 ongoing studies exploring innovative approaches such as Trastuzumab deruxtecan and combination therapies. Boston, Massachusetts also offers a robust landscape of 16 active trials investigating various treatment options. Los Angeles, California and New york, New York contribute significantly to gastric cancer research with their respective number of ongoing studies focused on different therapeutic interventions. These cities provide individuals battling gastric cancer access to cutting-edge clinical trials that hold promise for improving outcomes and advancing the field of care.

Which are the top treatments for gastric cancer being explored in clinical trials?

Exciting progress is being made in the field of gastric cancer treatment, with several cutting-edge therapies currently undergoing exploration in clinical trials. Notably, radiation therapy has emerged as a frontrunner, showing promise through three active trials and six all-time gastric cancer studies since 2016. Pembrolizumab follows closely behind with two ongoing trials and an impressive track record of 38 clinical trials dedicated to gastric cancer since its introduction in 2015. Equally noteworthy is trastuzumab deruxtecan, which entered the scene just last year but has already garnered attention for its involvement in two active and three all-time gastric cancer trials. Also making strides is nivolumab, engaged in two current investigations and having accumulated a respectable tally of 21 all-time clinical trials for gastric cancer since 2015. These advancements reflect the tireless efforts of researchers striving to improve outcomes for patients battling this challenging disease.

What are the most recent clinical trials for gastric cancer?

In the field of gastric cancer research, recent clinical trials offer promising advancements. One noteworthy trial is Arm B, which explores a combination of clinic-based and at-home treatments for gastric cancer patients. Additionally, Part B Expansion investigates new approaches to tackle this disease in its early stages. Another significant study focuses on the use of Olympus GIF 190 endoscope as a diagnostic tool in detecting gastric cancer. Furthermore, therapeutic options like gastrectomy with HIPEC have shown promise in Phase 2 trials. Finally, the investigation into Olaparib's effectiveness against gastric cancer marks another critical development. These ongoing trials hold great potential for improving outcomes and transforming the landscape of gastric cancer treatment moving forward.

What gastric cancer clinical trials were recently completed?

Several recent clinical trials have made significant contributions to the field of gastric cancer research. Noteworthy among them is a trial sponsored by OncXerna Therapeutics, Inc., which concluded in September 2019 and explored the potential benefits of Bavituximab. Additionally, City of Hope Medical Center's completed trial investigated Pembrolizumab in April 2019. Fate Therapeutics' FT500 study, completed in February 2019, also highlighted promising therapeutic avenues for this challenging disease. While these advances represent major strides forward, it is crucial to continue building upon their findings to further enhance treatment options for patients with gastric cancer.